116 related articles for article (PubMed ID: 1979362)
1. Optimization of immunocytochemical P-glycoprotein assessment in multidrug-resistant plasma cell myeloma using three antibodies.
Grogan T; Dalton W; Rybski J; Spier C; Meltzer P; Richter L; Gleason M; Pindur J; Cline A; Scheper R
Lab Invest; 1990 Dec; 63(6):815-24. PubMed ID: 1979362
[TBL] [Abstract][Full Text] [Related]
2. Decreased P-glycoprotein expression in multidrug-sensitive and -resistant human myeloma cells induced by the cytokine leukoregulin.
Evans CH; Baker PD
Cancer Res; 1992 Nov; 52(21):5893-9. PubMed ID: 1356622
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the human MDR3 P-glycoprotein and its recognition by P-glycoprotein-specific monoclonal antibodies.
Schinkel AH; Roelofs EM; Borst P
Cancer Res; 1991 May; 51(10):2628-35. PubMed ID: 1673638
[TBL] [Abstract][Full Text] [Related]
4. A sensitive method for immunocytochemical detection of P-glycoprotein in multidrug-resistant human ovarian carcinoma cell lines.
Chan HS; Bradley G; Thorner P; Haddad G; Gallie BL; Ling V
Lab Invest; 1988 Dec; 59(6):870-5. PubMed ID: 2904510
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of flow cytometry for multidrug resistance detection in low resistance K562 cells using daunorubicin and monoclonal antibodies.
Van Acker KL; Van Hove LM; Boogaerts MA
Cytometry; 1993 Oct; 14(7):736-46. PubMed ID: 7902231
[TBL] [Abstract][Full Text] [Related]
6. Severe combined immunodeficiency (SCID) mouse modeling of P-glycoprotein chemosensitization in multidrug-resistant human myeloma xenografts.
Bellamy WT; Odeleye A; Huizenga E; Dalton WS; Weinstein RS; Grogan TM
Clin Cancer Res; 1995 Dec; 1(12):1563-70. PubMed ID: 9815957
[TBL] [Abstract][Full Text] [Related]
7. Evidence for cytoplasmic P-glycoprotein location associated with increased multidrug resistance and resistance to chemosensitizers.
Abbaszadegan MR; Cress AE; Futscher BW; Bellamy WT; Dalton WS
Cancer Res; 1996 Dec; 56(23):5435-42. PubMed ID: 8968098
[TBL] [Abstract][Full Text] [Related]
8. Elimination of chemoresistant multiple myeloma clonogenic colony-forming cells by combined treatment with a plasma cell-reactive monoclonal antibody and a P-glycoprotein-reactive monoclonal antibody.
Tong AW; Lee J; Wang RM; Dalton WS; Tsuruo T; Fay JW; Stone MJ
Cancer Res; 1989 Sep; 49(17):4829-34. PubMed ID: 2569359
[TBL] [Abstract][Full Text] [Related]
9. Nuclear immunolocalization of P-glycoprotein in multidrug-resistant cell lines showing similar mechanisms of doxorubicin distribution.
Baldini N; Scotlandi K; Serra M; Shikita T; Zini N; Ognibene A; Santi S; Ferracini R; Maraldi NM
Eur J Cell Biol; 1995 Nov; 68(3):226-39. PubMed ID: 8603675
[TBL] [Abstract][Full Text] [Related]
10. Immunochemical detection of the multidrug resistance-associated protein MRP in human multidrug-resistant tumor cells by monoclonal antibodies.
Flens MJ; Izquierdo MA; Scheffer GL; Fritz JM; Meijer CJ; Scheper RJ; Zaman GJ
Cancer Res; 1994 Sep; 54(17):4557-63. PubMed ID: 7914828
[TBL] [Abstract][Full Text] [Related]
11. Characterization of monoclonal antibodies recognizing a Mr 180,000 P-glycoprotein: differential expression of the Mr 180,000 and Mr 170,000 P-glycoproteins in multidrug-resistant human tumor cells.
Meyers MB; Rittmann-Grauer L; O'Brien JP; Safa AR
Cancer Res; 1989 Jun; 49(12):3209-14. PubMed ID: 2566379
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a new drug-resistant human myeloma cell line that expresses P-glycoprotein.
Dalton WS; Durie BG; Alberts DS; Gerlach JH; Cress AE
Cancer Res; 1986 Oct; 46(10):5125-30. PubMed ID: 2875788
[TBL] [Abstract][Full Text] [Related]
13. The expression of the multidrug transporter P-170 glycoprotein in remission phase is associated with early and resistant relapse in multiple myeloma.
Musto P; Lombardi G; Matera R; Carotenuto M
Haematologica; 1991; 76(6):513-6. PubMed ID: 1687943
[TBL] [Abstract][Full Text] [Related]
14. Multifactorial resistance to adriamycin: relationship of DNA repair, glutathione transferase activity, drug efflux, and P-glycoprotein in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia.
Deffie AM; Alam T; Seneviratne C; Beenken SW; Batra JK; Shea TC; Henner WD; Goldenberg GJ
Cancer Res; 1988 Jul; 48(13):3595-602. PubMed ID: 2897875
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological and biological evidence for differing mechanisms of doxorubicin resistance in two human tumor cell lines.
Slovak ML; Hoeltge GA; Dalton WS; Trent JM
Cancer Res; 1988 May; 48(10):2793-7. PubMed ID: 2896069
[TBL] [Abstract][Full Text] [Related]
16. Binding diversity of antibodies against external and internal epitopes of the multidrug resistance gene product P-glycoprotein.
Lehne G; De Angelis P; Clausen OP; Egeland T; Tsuruo T; Rugstad HE
Cytometry; 1995 Jul; 20(3):228-37. PubMed ID: 7587708
[TBL] [Abstract][Full Text] [Related]
17. Comparison of three commercially available antibodies for flow cytometric monitoring of P-glycoprotein expression in tumor cells.
Krishan A; Sauerteig A; Stein JH
Cytometry; 1991; 12(8):731-42. PubMed ID: 1686582
[TBL] [Abstract][Full Text] [Related]
18. P-glycoprotein expression and in vitro reversion of doxorubicin resistance by verapamil in clinical specimens from acute leukaemia and myeloma.
Solary E; Bidan JM; Calvo F; Chauffert B; Caillot D; Mugneret F; Gauville C; Tsuruo T; Carli PM; Guy H
Leukemia; 1991 Jul; 5(7):592-7. PubMed ID: 1677057
[TBL] [Abstract][Full Text] [Related]
19. Verapamil reversal of doxorubicin resistance in multidrug-resistant human myeloma cells and association with drug accumulation and DNA damage.
Bellamy WT; Dalton WS; Kailey JM; Gleason MC; McCloskey TM; Dorr RT; Alberts DS
Cancer Res; 1988 Nov; 48(22):6365-70. PubMed ID: 3180056
[TBL] [Abstract][Full Text] [Related]
20. Tissue distribution of P-glycoprotein encoded by a multidrug-resistant gene as revealed by a monoclonal antibody, MRK 16.
Sugawara I; Kataoka I; Morishita Y; Hamada H; Tsuruo T; Itoyama S; Mori S
Cancer Res; 1988 Apr; 48(7):1926-9. PubMed ID: 2894894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
